16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategy.

Moshfeghi, Andrew A; Morales-Canton, Virgilio; Quiroz-Mercado, Hugo; Velez-Montoya, Raul; Zavala-Ayala, Alicia; Shusterman, Eugene Mark; Kaiser, Peter K; Sanislo, Steven R; Gertner, Michael; Moshfeghi, Darius M

Moshfeghi, Andrew A; Morales-Canton, Virgilio; Quiroz-Mercado, Hugo; Velez-Montoya, Raul; Zavala-Ayala, Alicia; Shusterman, Eugene Mark; Kaiser, Peter K; Sanislo, Steven R; Gertner, Michael; Moshfeghi, Darius M.

Affiliation

Moshfeghi AA; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida, USA.

Br J Ophthalmol ; 96(10): 1320-4, 2012 Oct.

Article in En | MEDLINE | ID: mdl-22895887

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Chemoradiotherapy/methods; Macular Degeneration/therapy; Radiation Dosage; Aged; Aged, 80 and over; Angiogenesis Inhibitors/administration & dosage; Angiogenesis Inhibitors/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration/pathology; Male; Middle Aged; Pilot Projects; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiation Dosage / Antibodies, Monoclonal, Humanized / Chemoradiotherapy / Macular Degeneration Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links